Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:19:12 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



C:AGN - Algernon Pharmaceuticals Inc. - http://www.algernonpharmaceuticals.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AGN - C  19.00.12·0.1350.50.13+0.018.353.06100.13  0.13  0.130.28  0.0512:35:24Apr 2415 min RT 2¢
CSE - C19.00.12·0.1350.50.13+0.018.346.0660.13  0.13  0.130.28  0.0512:35:2415 min
NEO ATS - U 0.13+0.018.37.0130.13  0.13  0.1312:35:2415 min
TriAct - M 0.120.031    Sep 01-2015 min

Recent Trades - All 10 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
12:35:24U0.130.014,50068 Leede2 RBCK
12:35:24C0.130.015,50068 Leede19 DesjardinsK
12:21:33U0.130.0150059 PI2 RBCK
12:21:33U0.130.012,00059 PI2 RBCK
12:21:33C0.130.018,50059 PI19 DesjardinsK
12:21:33C0.130.012,00059 PI2 RBCK
11:02:03M0.115-0.005257 TD Sec7 TD SecE
10:28:25C0.130.015,0001 Anonymous2 RBCK
09:45:53C0.130.012,00059 PI2 RBCK
09:30:00C0.130.0123,00059 PI7 TD SecK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-01 09:37C:AGN0.11News ReleaseAlgernon to move forward with DMT stroke research
2024-03-27 12:20C:AGN0.09Resume TradingAlgernon Pharmaceuticals to resume at 9:45 a.m. PT
2024-03-27 12:17C:AGN0.12News ReleaseAlgernon sells ifenprodil research program to Seyltx
2024-03-27 10:24C:AGN0.09Halt TradingAlgernon Pharmaceuticals halted at 7:22 a.m. PT
2024-01-31 10:12C:AGN0.08News ReleaseAlgernon to receive Chinese repirinast patent
2024-01-11 10:22C:AGN0.085News ReleaseAlgernon receives notice of allowance in Japan
2023-12-29 17:56C:AGN0.065SEDAR MD & ASEDAR MD & A
2023-12-29 17:49C:AGN0.065SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-12-27 16:10C:AGN0.07News ReleaseAlgernon closes $280,000 private placement
2023-12-27 10:21C:AGN0.07News ReleaseAlgernon increases private placement to $280,000
2023-12-12 19:48C:AGN0.085News ReleaseAlgernon arranges $150,000 private placement
2023-11-30 09:50C:AGN0.07News ReleaseAlgernon to receive Chinese patent for Repirinast
2023-11-22 09:17C:AGN0.07News ReleaseAlgernon to sell ifenprodil research program to Seyltx
2023-11-08 10:30C:AGN0.075News ReleaseAlgernon receives Japanese patent for Repirinast
2023-09-06 09:54C:AGN0.16News ReleaseAlgernon receives U.S. patent for repirinast drug
2023-08-08 10:16C:AGN0.175News ReleaseAlgernon subsidiary finalizes phase 2 DMT stroke study
2023-07-28 16:29C:AGN0.20SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-14 18:12C:AGN0.22News ReleaseAlgernon arranges $205,000 private placement
2023-06-27 09:47C:AGN0.19News ReleaseAlgernon hires Maxim for advisory services
2023-06-05 09:37C:AGN0.235News ReleaseAlgernon doses final cohort in AP-188 phase 1 study